R Pg Family Wealth Advisory, LLC Bristol Myers Squibb CO Transaction History

R Pg Family Wealth Advisory, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 12, 2020	SELL	$49.21 - $64.19 $18,207 - $23,750	-370 Closed	0 $0
Q2 2019 Aug 13, 2019	SELL	$44.62 - $49.34 $11,021 - $12,186	-247 Reduced 40.03%	370 $0
Q1 2019 May 14, 2019	BUY	$45.12 - $53.8 $15,340 - $18,292	340 Added 122.74%	617 $0
Q3 2018 Nov 14, 2018	BUY	$55.19 - $62.25 $15,287 - $17,243	277 New	277 $0

2,428

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of R Pg Family Wealth Advisory, LLC, based on Form 13F filings with the SEC.

Stay updated on R Pg Family Wealth Advisory, LLC with notifications on news.